Mechanistically, XIST competes with miR-101 to upregulate C/EBP and KLF6 expression, which inhibits macrophage polarization toward the M2 phenotype, thereby suppressing BC cell proliferation and migration (85). This evidence concerns the gene XIST and breast cancer.